Boyer, Emilien
Deltenre, Louise
Dourte, Marion
Colmant, Lise
Paître, Esther
Sleegers, Kristel
Suelves, Nuria
Hanseeuw, Bernard
Kienlen-Campard, Pascal
Funding for this research was provided by:
Fondation Louvain
Fondation St Luc
Fonds européen de développement regional
UCLouvain Action de Recherche Concertée (ARC21/26-114, ARC21/26-114)
Fonds De La Recherche Scientifique - FNRS (ASP40001844, CCL40010417, FNRS J.0106.22)
Fonds de la Recherche Fondamentale Stratégique - Walloon Excellence in Life Sciences and Biotechnology (40010035)
SAO-FRA Alzheimer’s Research Foundation (SAO-FRA 2020/0028, SAO-FRA 2018/0025)
Queen Elisabeth Medical Foundation
Article History
Received: 15 April 2024
Accepted: 19 June 2024
First Online: 28 June 2024
Declarations
:
: Participants provided informed consent and demonstrated comprehension of the study’s objectives and procedures. All experimental protocols adhered to the ethical standards set forth in the Declaration of Helsinki and underwent approval by local Institutional Review Boards (Institutional Ethics Committee of Clinics Saint-Luc University Hospital, 1200 Brussels, Belgium, Ethical protocols UCL-2022-473; UCL-2016-121 and UCL-2018-119).
: Not applicable.
: K.S is a member of the Alzheimer’s Research & Therapy editorial board. She was not involved in the assessment or decision-making process for this manuscript.